Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
VA Medical Center, Houston Baylor College of Medicine |
---|---|
Information provided by: | VA Medical Center, Houston |
ClinicalTrials.gov Identifier: | NCT00304395 |
The purpose of this research is to identify cases from patients who have been referred for consultation to the Infectious Disease Section at the VAMC, Houston, and to compare them with other cases of CAP in order to determine wheteher there are features that might enable non-CAP cases to be distinguished from CAP.
Study Type: | Observational |
Study Design: | Natural History, Cross-Sectional, Defined Population, Retrospective Study |
Official Title: | Pulmonary Infections Masquerading as Community-Acquired Pneumonia |
Estimated Enrollment: | 60 |
Guidelines to treat community acquired pneumonia (CAP) have been developed and widely promulgated by important professional societies in the past 10 years. The impetus to do so came from the observation that practicing physicians were using a wide array of approaches to this common infection, many of which were substandard.
The Infectious Disease Society of America (IDSA) and American Thoracic Society (ATS) have been leaders in this field, publishing recommendations separately between 1993 and 2003. The PI served on the IDSA committee and coauthored the publication in 2000 and the update in 2003. In 2004, a decision was made by the two professional societies to merge the committees and make a single joint set of recommendations; the PI is a member of that joint committee and a new document is being prepared for publication.
The PI has observed a tendency to apply these guidelines to cases that might masquerade as CAP but are actually attributable to other conditions, such as lung cancer, tuberculosis and histoplasmosis. Further, the recommendations do not adequately cover pneumonia due to Staphylococcus aureus.
The purpose of the research is to identify cases from the consult records of the Infectious Disease Section at the VAMC, Houston, and to compare them with other cases of CAP in order to determine whether there are features that might enable non-CAP cases to be distinguished from CAP.
Ages Eligible for Study: | 18 Years to 64 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Daniel M Musher, M.D. | 713-794-7384 | dmusher@bcm.tmc.edu |
United States, Texas | |
Michael E. DeBakey Veterans Affairs Medical Center | Recruiting |
Houston, Texas, United States, 77030 | |
Contact: Daniel M Musher, M.D. 713-794-7384 dmusher@bcm.tmc.edu | |
Contact: Nancy L Logan, M.A. 713-794-7384 njarrar@bcm.tmc.edu | |
Principal Investigator: Daniel M Musher, M.D. |
Principal Investigator: | Daniel M Musher, M.D. | Baylor College of Medicine, Houston VA Medical Center |
Study ID Numbers: | H-17555 |
Study First Received: | March 16, 2006 |
Last Updated: | March 16, 2006 |
ClinicalTrials.gov Identifier: | NCT00304395 History of Changes |
Health Authority: | United States: Institutional Review Board |
Community Acquired Pneumonia CAP |
Respiratory Tract Infections Respiratory Tract Diseases Lung Diseases Pneumonia |
Respiratory Tract Infections Respiratory Tract Diseases Lung Diseases Pneumonia |